These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31144016)

  • 1. Counting Steps: A New Way to Monitor Patients with Pulmonary Arterial Hypertension.
    Sehgal S; Chowdhury A; Rabih F; Gadre A; Park MM; Li M; Wang X; Highland KB;
    Lung; 2019 Aug; 197(4):501-508. PubMed ID: 31144016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical activity in incident patients with pulmonary arterial and chronic thromboembolic hypertension.
    Saxer S; Lichtblau M; Berlier C; Hasler ED; Schwarz EI; Ulrich S
    Lung; 2019 Oct; 197(5):617-625. PubMed ID: 31263960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The longitudinal use of EmPHasis-10 and CAMPHOR questionnaire health-related quality of life scores in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Hendriks PM; van Thor MCJ; Wapenaar M; Chandoesing P; van den Toorn LM; van den Bosch AE; Post MC; Boomars KA
    Respir Med; 2021 Sep; 186():106525. PubMed ID: 34218166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digital Tracking of Physical Activity, Heart Rate, and Inhalation Behavior in Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost: Observational Study (VENTASTEP).
    Stollfuss B; Richter M; Drömann D; Klose H; Schwaiblmair M; Gruenig E; Ewert R; Kirchner MC; Kleinjung F; Irrgang V; Mueller C
    J Med Internet Res; 2021 Oct; 23(10):e25163. PubMed ID: 34623313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline NT-proBNP correlates with change in 6-minute walk distance in patients with pulmonary arterial hypertension in the pivotal inhaled treprostinil study TRIUMPH-1.
    Frantz RP; McDevitt S; Walker S
    J Heart Lung Transplant; 2012 Aug; 31(8):811-6. PubMed ID: 22759797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Noninvasive Endpoints in Predicting Long-Term Outcomes in Pulmonary Arterial Hypertension.
    Wronski SL; Mordin M; Kelley K; Anguiano RH; Classi P; Shen E; Manaker S
    Lung; 2020 Feb; 198(1):65-86. PubMed ID: 31722043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide in pediatric patients with pulmonary arterial hypertension.
    Takatsuki S; Wagner BD; Ivy DD
    Congenit Heart Dis; 2012; 7(3):259-67. PubMed ID: 22325151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between meeting daily step count goals with ambulatory function and quality of life in patients with claudication.
    Gardner AW; Montgomery PS; Wang M; Shen B
    J Vasc Surg; 2021 Jun; 73(6):2105-2113. PubMed ID: 33253870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan.
    Rotondo C; Praino E; Nivuori M; di Serio F; Lapadula G; Iannone F
    Int J Rheum Dis; 2017 Jan; 20(1):90-96. PubMed ID: 26218502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Step climbing capacity in patients with pulmonary hypertension.
    Fox BD; Langleben D; Hirsch A; Boutet K; Shimony A
    Clin Res Cardiol; 2013 Jan; 102(1):51-61. PubMed ID: 22875547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-Life Experience with Selexipag as an Add-On Therapy to Oral Combination Therapy in Patients with Pulmonary Arterial or Distal Chronic Thromboembolic Pulmonary Hypertension: A Retrospective Analysis.
    Berlier C; Schwarz EI; Saxer S; Lichtblau M; Ulrich S
    Lung; 2019 Jun; 197(3):353-360. PubMed ID: 30963265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guideline implementation and early risk assessment in pulmonary arterial hypertension associated with congenital heart disease: A retrospective cohort study.
    Deng X; Jin B; Li S; Li Y; Zhou H; Wu Y; Yan M; Hu Y; Qiu Q; Zhang G; Zheng X
    Clin Respir J; 2019 Nov; 13(11):693-699. PubMed ID: 31419027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of questionnaire and accelerometer-based assessments of physical activity in patients with heart failure with preserved ejection fraction: clinical and prognostic implications.
    Schmidt C; Santos M; Bohn L; Delgado BM; Moreira-Gonçalves D; Leite-Moreira A; Oliveira J
    Scand Cardiovasc J; 2020 Apr; 54(2):77-83. PubMed ID: 31894707
    [No Abstract]   [Full Text] [Related]  

  • 14. Biological serum markers in the management of pediatric pulmonary arterial hypertension.
    Van Albada ME; Loot FG; Fokkema R; Roofthooft MT; Berger RM
    Pediatr Res; 2008 Mar; 63(3):321-7. PubMed ID: 18287971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous hemodynamic monitoring in patients with pulmonary arterial hypertension.
    Frantz RP; Benza RL; Kjellström B; Bourge RC; Barst RJ; Bennett TD; McGoon MD
    J Heart Lung Transplant; 2008 Jul; 27(7):780-8. PubMed ID: 18582809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oscillatory whole-body vibration improves exercise capacity and physical performance in pulmonary arterial hypertension: a randomised clinical study.
    Gerhardt F; Dumitrescu D; Gärtner C; Beccard R; Viethen T; Kramer T; Baldus S; Hellmich M; Schönau E; Rosenkranz S
    Heart; 2017 Apr; 103(8):592-598. PubMed ID: 28100544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension.
    Chin KM; Rubin LJ; Channick R; Di Scala L; Gaine S; Galiè N; Ghofrani HA; Hoeper MM; Lang IM; McLaughlin VV; Preiss R; Simonneau G; Sitbon O; Tapson VF
    Circulation; 2019 May; 139(21):2440-2450. PubMed ID: 30982349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of N-terminal pro-brain-type natriuretic peptide with hemodynamics and functional capacity in therapy-naive precapillary pulmonary hypertension: results from a cohort study.
    Berghaus TM; Kutsch J; Faul C; von Scheidt W; Schwaiblmair M
    BMC Pulm Med; 2017 Dec; 17(1):167. PubMed ID: 29202745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Submaximal exercise testing may be superior to the 6-min walk test in assessing pulmonary arterial hypertension disease severity.
    Neal JE; Lee AS; Burger CD
    Clin Respir J; 2014 Oct; 8(4):404-9. PubMed ID: 24308300
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.